SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-17-006958
Filing Date
2017-04-24
Accepted
2017-04-24 08:05:31
Documents
5
Period of Report
2017-04-24
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K life-8k_20170424.htm 8-K 41567
2 EX-99.1 life-ex991_20.htm EX-99.1 19330
3 EX-99.2 life-ex992_70.htm EX-99.2 12641
4 GRAPHIC g20170424011816305118.jpg GRAPHIC 3474
5 GRAPHIC gfm04k2dpbff000001.jpg GRAPHIC 2101344
  Complete submission text file 0001564590-17-006958.txt   2973740
Mailing Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121 858-731-8389
aTYR PHARMA INC (Filer) CIK: 0001339970 (see all company filings)

IRS No.: 203435077 | State of Incorp.: DE
Type: 8-K | Act: 34 | File No.: 001-37378 | Film No.: 17777235
SIC: 2836 Biological Products, (No Diagnostic Substances)